JP Morgan Provides Color on St. Jude Medical, Overweight

JP Morgan provided color on St. Jude Medical STJ ahead of the company's quarterly earnings report, which is due on July 20. In a research report published today, JP Morgan states, “St. Jude is scheduled to report 2Q results next Wednesday, July 20th. Our forecast calls for revenues of $1.430B (+8.9% reported, +4.9% constant currency) and EPS of $0.84 (+6.0%).” At the moment, JP Morgan has an Overweight rating and a price target of $57 placed on the company's stock. On Thursday, STJ closed the day at $45.55.